Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Current Leases (2020 - 2026)

Immuneering's Current Leases history spans 7 years, with the latest figure at $412835.0 for Q1 2026.

  • On a quarterly basis, Current Leases rose 17.11% to $412835.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $412835.0, a 17.11% increase, with the full-year FY2025 number at $397104.0, up 17.33% from a year prior.
  • Current Leases came in at $412835.0 for Q1 2026, up from $397104.0 in the prior quarter.
  • The five-year high for Current Leases was $412835.0 in Q1 2026, with the low at $265419.0 in Q1 2022.
  • Historically, Current Leases has averaged $336540.2 across 5 years, with a median of $332675.0 in 2023.
  • Biggest five-year swings in Current Leases: surged 272.84% in 2022 and later dropped 20.76% in 2023.
  • Year by year, Current Leases stood at $378723.0 in 2022, then fell by 20.76% to $300107.0 in 2023, then increased by 12.77% to $338438.0 in 2024, then increased by 17.33% to $397104.0 in 2025, then rose by 3.96% to $412835.0 in 2026.
  • Business Quant data shows Current Leases for IMRX at $412835.0 in Q1 2026, $397104.0 in Q4 2025, and $381760.0 in Q3 2025.